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Natural Proteinase Inhibitors
Distribution, Specificity, Mode of Action, and Physiological Significance1)
By E. WERLE and GERTRUD ZICKGRAF-RÜDEL
Institut für Klinische Chemie und Klinische Biochemie der Universität München
(Eingegangen am 2. September 1971)
There are many ways in which the action of proteolytic enzymes may be controlled by the living organism. One form of control employs
proteinase inhibitors, a group of polypeptides, proteins, and glycoproteins. These inhibitors occur in numerous plants and animals. Their
methods of isolation are discussed briefly.
The inhibitors are differentiated with regard to their mode of action — permanent, temporary, and progressive inhibition — also with
regard to their specificity and some physicochemical properties. In the case of temporary inhibition a distinct peptide bond in the reactive
site of the inhibitor is split by the respective enzyme.
The elucidation of the three dimensional structure of the polyvalent basic inhibitor from bovine lung offers another opportunity to clarify
the molecular mechanism of the enzyme — inhibitor reaction.
Our present knowledge of their physiological significance is discussed with respect to various inhibitors. The growth retarding effect in
experimental animals which are fed leguminosae is partly caused by proteinase inhibitors. Recent experiments show that the inhibitors in
solanaceae are a reserve protein, which is not degraded enzymatically and which is found in different plant tissues depending on the state
of development of the plant. Furthermore a protective function of the inhibitors is discussed.
The physiological significance of the inhibitor from vesiculary glands and from sperm plasma is the best known compared with other
mammalian inhibitors. This inhibitor is involved in the process of decapacitation by complex formation with the acrosomal enzyme acrosin
of spermatozoa. The biosynthesis of this inhibitor is hormone dependent. In the human female cervical secretion, an inhibitor has been
demonstrated, which may influence the sperm migration through the cervix.
Possibly an inhibitor from colostrum protects colostral immune bodies from undue degradation in the gastrointestinal tract of the new-
born. The primary structure of the bovine colostrum inhibitor resembles that of the polyvalent basic bovine inhibitor to a fairly high
degree.
The inhibitor from nasal and bronchial mucous membranes, from lacrimal glands, and from submandibularis glands are thought to have
a protective function for the inner body surface mainly against bacterial and leucocytic proteinases. This may also be the function of
mingin, the inhibitor which is excreted with the urine. A few results indicate that inhibitors from skin also have a protective function.
The inhibitors from serum are potent factors in the regulation of coagulation and fibrinolysis. High concentration, a broad inhibition
spectrum, and different mechanisms of action of the 6 known serum inhibitors provide a high security against an unphysiological activation
of the enzymes of coagulation and fibrinolysis.
Der Organismus bedient sich zur Kontrolle der Wirkung proteolytischer Enzyme unter anderem der Proteinaseinhibitoren, einer Gruppe
von Polypeptiden, Proteinen und Glycoproteinen. Diese Inhibitoren sind im Pflanzen- und Tierreich weit verbreitet. Methoden der
Isolierung werden kurz gestreift.
Die Inhibitoren können unterteilt werden nach der Art des Wirkungsmechanismus — permanente, temporäre und progressive Inhi-
bierung — ferner aufgrund ihrer Spezifitat und gewisser physikochemischer Eigenschaften. Bei der temporären Inhibierung kommt es zu
einer reversiblen Spaltung einer bestimmten Peptidbindung im reaktiven Zentrum des Inhibitors durch das zu hemmende Enzym.
Die Aufklarung der 3-dimensionälen Struktur des polyvalenten, basischen Inhibitors aus Rinderlunge ermöglichte weitere Einblicke in
den molekularen Mechanismus der Enzym-Inhibitor-Reaktion.
Anhand von einzelnen Beispielen werden die vorläufigen Kenntnisse über die physiologische Bedeutung der Inhibitoren dargestellt. Der
bei der Fütterung mit rohen Leguminosen beobachtete wachstumshemmende Effekt kann zum Teil auf Proteinaseinhibitoren zurückge-
führt werden. Neuere Untersuchungen zeigen, daß in Solanaceen die Inhibitoren ein enzymatisch nicht angreifbares Reserveprotein dar-
stellen, das je nach Wachstumsstadium in verschiedenen Pflanzenteilen gefunden wird. Außerdem wird eine Schutzfunktion der Inhibi-
toren diskutiert.
Von den Inhibitoren des Säugetierorganismus ist die physiologische Bedeutung des Inhibitors aus Vesicularisdrüsen und Spermaplasma
am besten aufgeklärt. Der Inhibitor ist wesentlich beteiligt am Vorgang der Dekapazitierung durch Komplexbildung mit dem Akro-
somenenzym Acrosin der Spermatozoen. Die Biosynthese dieses Inhibitors ist hormonabhängig. Auch im weiblichen Cervixsekret wurde
ein Inhibitor nachgewiesen; der die Migration der Spermien durch die Cervix beeinflussen soll.
Ein Inhibitor aus Colostrum schützt möglicherweise die mit dem Colostrum dem Neugeborenen zugeführten Immunkörper vor vor-
zeitigem Abbau im Magen-Darm-Trakt. Der Colostruminhibitor des Rindes gleicht in seiner Primärstruktur weitgehend dem poly-
valenten, basischen Rinder-Inhibitor.
Den Inhibitoren aus Nasen- und Bronchialschleimhäut, aus Tränendrüsen sowie aus den Mundspeicheldrüscn wird eine Schutzfunktion
für die innere Körperoberfläche, hauptsächlich gegen Proteinasen von Leukocyten und Bakterien zugeschrieben. Diese Funktion kommt
wohl auch dem mit dem Harn ausgeschiedenen Inhibitor, dem Mingin, zu. Es gibt Hinweise darauf, daß Inhibitoren der Haut ebenfalls
eine Schutzfunktion ausüben.
Die Inhibitoren des Serums sind wichtige Faktoren in der Regulierung von Blutgerinnung und Fibrinolyse. Hohe Konzentrationen,
breite Wirkungsspektren und unterschiedliche Wirkungsmechanismen der 6 bekannten Serum-Inhibitoren bewirken ein hohes Maß an
Sicherheit vor unphysiologischen Entgleisungen der Enzymaktivitäten der Gerinnung und Fibrinolyse.
*) Lecture given at the XXV International Congress of Physiological Sciences, Munich July 25—31,1971.
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Tab. 1
Inhibitors of animal origin
Occurence, molecular weight, and inhibitory specificity
Source of inhibitors
Pancreas (KAZAL)
Bovine organs (Trasylol)
Colostrum
Seminal vesicles, semen I :(guinea pig) II:
Gl. submandib. (dog)
Leeches (Hirudin)
Leeches (Bdelline)
Ovomucoid
Ovo-inhibitor
MW approx. Trypsin
6000 4-
6500 +
6000—10500 4-
6000 4·
6000 4
11000 4
9000 —
6000 4
27000 4
49000 4
Chymo-
trypsin
—
+
—
-f
—(40
—
+
 .
Inhibition of
Plasmin Thrombin Organ Serum
Kallikrein Kallikrein
, « 1
— ' ~ 1
4- — —
— -j-
•f — . .
V T/
Bact.
Proteases
—
+
Tab. 2
Plant inhibitors
Occurence, molecular weight, and inhibitory specificity
Source of inhibitors
Soybean (KUNITZ)
Soybean (BOWMAN/BIRK)
Potatoes (RYAN)
Potatoes (HOCHSTRASSER)
Peanuts
Limabeans
Gramineae
MW approx. Trypsin
22000 +
8000 +
4-
24000 +
18000 +
18000 +
18000 +
Inhibition of
Chymo- Plasmin Thrombin Organ
trypsin Kallikrein
H-
4- + — —
H* 4* -!=r!" —
— -f- — —
— + ^— — ^
Serum
Kallikrein
+
4·
4·
—
—
Tab. 3
Types of inhibition
Natural proteinase inhibitors classified according to their different
modes of action (FRITZ (2))
Permanent Temporary Progressive
Plant seeds:
Soybeans
Potatoes
Bovine organs (Trasylol)
Leeches (Hirudin)
Human blood serum:
*x-Antitrypsin (trypsin)
<*a-Macroglobulin (plasmin)
Source of inhibitors:
Pancreas (KAZAL-typ)
Seminal vesicles and · jKj '
Seminal plasma
Gl. submandib. .
Leeches (Bdelline) J
Ovomucoid
Human blood serum":
o^-Antitrypsin (plasmin, källikrein)
«^Macroglobulin (thrombin)
Antithrombin-III (thrombin)
In the living organism there are many methods for the
control of enzymatic activities. In the field of proteo-
lytic enzymes this control is in many cases achieved by
a group of polypeptides, proteins, and glycoproteins,
the so-called proteinase inhibitors. "The interaction
between inhibitor and enzyme must involve a very
accurate fit between the reactive sites of both proteins.
Why such an interaction leads to an enzymatic de-
gradation in the case of a substrate and to inhibition in
the case of an inhibitor is still not fully understood."
Occurrence and Methods of isolation
This survey will deal with protein-like inhibitors of
endopeptidases both from plants and animals. The
Tables 1 and 2 show the occurrence of such proteinase
inhibitors together with their inhibitory specificity.
'Completeness is not intended. Plant inhibitors are
located nearly exclusively in the seeds. In animals in-
hibitors are found in different tissues and body fluids,
especially in blood plasma.
In^addition to classical methods of protein isolation,
the inhibitors may be isolated by affinity chromato-
graphy. This method was mainly developed for the
isolation of proteinase inhibitors by FRITÄ and co-
workers (1) in our laboratory: Proteinases like trypsin
are covalently bound to waterinsoluble resins. Such
enzyme resins bind specifically the inhibitors from
crude tissue extracts. Conta_minating substances are
easily washed off by salt buffer solutions. The inhibitor
is then dissociated from the enzyme resin complex by
suitable salt solutions. The enzyme resins can be used
many times for this procedure. Observations in our
laboratory have shown that by chemical variation of
the insoluble carriers the binding of inhibitors to the
fixed enzyme can be facilitated. On the. .other hand
insolubilized inhibitors allow the isolation of corre-
sponding enzymes more simply and more rapidly than
by conventional methods.
Mode of Action, Inhibitor Specificity, and Reactive
Centre
The inhibitors are classified not only with respect to
their specificity, to their molecular weight, and other
physicochemical properties, but also with respect to
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the types of inhibition. There are 3 main types of
inhibition (2) (Tab. 3):
1. The permanent inhibition with the following criteria:
a) the equilibrium of inhibition is reached within
seconds or a few minutes.
b) The rate of attainment of equilibrium is virtually
independent of the temperature of incubation.
c) The degree of inhibition remains unaltered for days.
d) The inhibitor enzyme binding is reversible. To this
group belong many inhibitors both from plants and
animals.
2. Temporary inhibition. The criteria for this type are
the same as for permanent inhibition, but the degree
of inhibition is slowly diminished with time of in-
cubation because the inhibitor is destroyed by the en-
zyme. In this way the enzyme becomes active again.
To this group belong most of the polypeptide inhibitors.
3. The progressive inhibition (slow reacting inhibitors).
Here attainment of equilibrium takes some hours at
25—37°. The reaction is strongly temperature depend-
ent. The complex bonding is irreversible.
This type of inhibition is hitherto known only for in-
hibitors from blood plasma.
The fact that there are inhibitors with more or less
widespread specificities provides another basis for
characterization. We know inhibitors specific for one
enzyme, inhibitors with one reactive centre for the
inhibition of different enzymes, e. g. the polyvalent
basic bovine inhibitor^ and inhibitors with different
centres for different enzymes. The reactive sites of
these inhibitors may be very close, i. e. overlapping, or
at opposite sites of the molecules, i. e. non-overlapping.
Some of these possibilities are realized in the inhi-
bitors of the egg white of various birds.
It may be emphasized that inhibitors occur for nearly
all types of proteinases especially for serine enzymes
which have a serine moiety in their active centre, for
metallo enzymes like polypeptidase B, for enzymes
with functional SH-groups like ficin or papain, and
even for the acid enzyme pepsin.
It was mainly the merit of LASKOWSKI, Jr. (3) to show
that the primary reaction in temporary inhibition is the
splitting of a distinct peptide bond of the inhibitor
molecule by the enzyme. In all cases studied by LAS-
KOWSKI, Jr. (3), HOCHSTRASSER (4), and TSCHESCHE (5)
a distinct arginine -X or lysine -X bond is cleaved during
enzyme inhibitor reaction (Tab. 4). The reversible
process at the so called reactive site of the inhibitor
does not impair inhibitory capacity. An equilibrium is
achieved between virgin (uncleaved) and modified
(reactive site cleaved) inhibitor. But if the reactive
arginine or lysine is split off by carboxypeptidase, the
inhibitory capacity is entirely lost. Substitution of the
reactive arginine of soybean trypsin inhibitor by lysine,
which was achieved by LASKOWSKI, Jr. (6), does not
alter inhibitory capacity and specificity.
Tab. 4
Amino acid sequence of the reactive sites of trypsin inhibitors from
plant and animal origin (for literature see HOCHSTRASSER (4))
Reactive Sites of Trypsin
Source of inhibitors
Glycine so/a
Zea mays
Triticum vulgäre
Secale cereale
Peanut
Ovomucoid
Pancreas
Hog
Dog
Cow
Cow lung
Inhibitors
Reactive sites
Arg-Ile
Arg-Leu
Arg- Ala
Arg-Ala
Arg- A la
Arg-Ala
Lys-Ile
Lys-?
Arg-Ile
Lys- A la
In the case of the basic bovine inhibitor not only the
amino acid composition and its sequence is known but
also, from the work of HUBER and coworkers (7, 8),
the three dimensional configuration (Fig. 1). The work
of ACHER (for literature see 1. c. (9)) and others revealed
that the free amino group of the lysine 15 moiety is the
reactive centre of the inhibitor. Its blockade leads to
the entire inactivation of the inhibitor.
This lysine 15 moiety is on an exposed site of the pear
shaped molecule of the inhibitor. Most of the basic,
positively charged amino acids are found at the upper
half of the molecule whereas the acidic negatively
charged ones are located at the basis of the molecule.
According to HUBER the exposed situation of the
reactive centre and the high dipole-moment are of
importance for the quick and correct orientation of the
inhibitor to the active centre of the appropriate en-
zymes.
Lys
Fig. 1
Figure 1 shows the pear-shaped three dimensional structure of basic
pancreatic trypsin inhibitor. The free amino group of Lys 15 is the
reactive site. The disulfide bridges (— S—S—) are located between
Cys 14 — Cys 38, Cys 30 — Cys 51, and Cys 5 — Cys 55. (HUBER and
coworkers 7)
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Inhibitors from plants
After this general survey we should consider important
inhibitors and their possible physiological functions,
starting with some observations on inhibitors from
plants.
The fact, that experimental feeding of rough soybeans
(Gljclne soja) had a growth retarding effect in
animals led to the detection of its potent trypsin
inhibitors (for literature see 1. c. (10)).
Experimental feeding of rough soybean meal to rats or
chicken leads also to an enlargement of the pancreas.
According to BIRK (11) this effect is elicited mainly by
the alcohol soluble trypsin-chymotrypsin inhibitor of
soybeans, a thermolabil factor which stimulates the
pancreas to produce excessive amounts of digestive
proteolytic enzymes. These proteins with essential
amino acids, especially sulfur containing ones, are
partly lost with the faeces. This is the main cause of the
inhibition of growth, which can be avoided by sup-
plementation of the food with methionine or cysteine
(for literature see 1. c. (10), (11)).
The numerous experiments with soybean trypsin in-
hibitors did not bring an exact explanation of the mode
of action on the pancreas. One assumption, which is
also cited by BIRK, suggests, that the inhibitor should
release a humoral factor, possibly pancreozymin, from
the mucosa of the small intestine, which in turn causes
the pancreas to produce augmented amounts of en-
zymes.
On the other hand soybean meal does not impair
animal or human growth when used in adequate
manner i. e. boiled or steam treated, whereby practi-
cally all of the inhibitor is destroyed. Nobody has ever
stated that nutrition on the basis of boiled potatoes has
any growth retarding effect in animals or man in spite
of the fact that rough potatoes (Solatium tuberosum) have
huge amounts of different inhibitors of the proteinases
of the mammalian digestive tract. Only feeding of
rough potatoes e. g. to pigs causes a decrease of the
digestibility of the potatoe protein to some 10%.
What is the physiological purpose of these inhibitors in
the plants in which they are synthetized? To our
present knowledge the inhibitors of soybeans do not
inhibit their own proteinases. Studies by BIRK with
soybean plants have shown that the trypsin-inhibiting
activity is confined to the seed as no such activity
has been detected in leaves, stems, and empty pods
(for literature see 1. c. (10), (11)).
In the Solanaceae family proteinase inhibitors are mainly
found in the tubers,' which like the seeds from Le-
guminosae are storage organs (for literature see 1. c. (10)).
No satisfactory explanation for the existence of these
inhibitors could be found for a long time. Recently
RYAN (12) reported on some remarkable findings from
his experiments with chymotrypsin inhibitor from
potatoes (for further literature see also 1. c. (12)). In
tubers the inhibitor concentration varies depending on
age and storage conditions. True seeds do not contain
the inhibitor. But in new plants either from sprouted
tubers or from true seeds the inhibitor primarily ap-
pears in the young leaves. When the plants develop new
tubers or rhizomes the inhibitor disappears from the
leaves and accumulates in the new tubers. If the rhi-
zomes are cut off the inhibitor seems to return to the
leaves but only if they are exposed to light. Furthermore
RYAN found that there exists a correlation between the
concentration of the inhibitor and the vacuolar bodies
in the different plant tissues.
RYAN suggests from his studies that the inhibitor is a
special type of reserve protein that is produced in a
controlled manner depending on the stage of develop-
ment of the plant. According to RYAN the inhibitor
could be a precursor of part of the cellular membrane,
but could also function in the regulation of proteolytic
enzymes in the plant or in some defensive mechanism.
In view of the presence of trypsin^like enzymes in stored
product pests such as Tenebrio motitor and of a Tribolium
proteinase inhibitor in soybean and wheat ((Triticum vul-
gare\ BIRK suggests (11) that plant proteinase inhi-
bitors may function in the defense against insects.
v
 Inhibitors from animal origin
It is not possible to discuss all proteinase inhibitors of
animal origin in this survey. The following consid-
erations were the cause for the present selection: in
spite of rather equal biochemical properties inhibitors
seem to have quite different physiological functions.
Some of them will be discussed here.
Recent findings on proteinäse inhibitors from sex
glands have revealed their physiological function in
connection with fertilization. The function of colostrum
inhibitor may also be correlated with the specific func-
tion of the synthetizing organ. According to our present
knowledge, however, most of the other inhibitors of
mammalian organism have a general protective
function within the synthetizing organ and for the
inner (and outer) surface of the body. (We omitted the
trypsin specific inhibitor from mammalian pancreas
and the bovine basic pancreatic inhibitor, and refer to
the survey by VOGEL, TRAUTSCHOLD and WERLE (10)).
Finally serum inhibitors are potent factors in the
regulation of coagulation and the kinin system.
Trypsin inhibitor from seminal vesicles
In 1965 HAENDLE of our research group (13, 14, 15)
found a trypsin inhibitory activity in sperm plasma of
several mammals including man. From quantitative,
estimations of several tissues of the male genital tract
(Tab. 5) we assume that biosynthesis is accomplished
mainly in the glandula vesicularis. From there the in-
hibitor is secreted into seminal plasma. Guinea pig
seminal vesicles have far the highest concentration ·
whereas those of man have the lowest of any species
examined so far.
The inhibitor is not active against chymotrypsin or
the kallikreins, but shows some activity against bac-
Z. klin. Chcm. u. klin. Biöchem. /10. Jahtg. 1972 / He£t 4 i
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Tab. 5
Trypsin inhibition activities (ImU) in male sex glands and their secre-
tions. (FiNK and coworkers (19» 9000-
Species
Man
Cattle
PigSheep
Rat
Mouse
Guinea pig
Hamster
ImU
Testes
70—100
40—70
90—120
100—200
90—130
100—220
60—90
per g tissue or
Epididymis
50-r80
50—80
70—110
90—130
100—200
300—400
80—120
ml plasma
Glandula
vesicul.
50—100
900—1500
500— 1000
250—500
1400—1600
2200—2700
3500—5000
300—600
Seminal
plasma
150—330
2400—3100
800—1200
The values were adopted from H. HAENDLE (15). One ImU (Inhibi-
tor-Milliunit) inhibits the activity of about 1 jug trypsin Novo
terial proteinase from Streptomyces griseus (13). Only the
sex glands of bulls contain in addition to the trypsin
inhibitor the already mentioned bovine polyvalent in-
hibitor, which occurs in many bovine tissues (14).
SCHUMACHER (16) reported on the presence of ar
antitrypsin in human seminal fluid, the concentration
being 40 to 100 times lower than in human serum.
Nothing is yet known with regard to the function and
origin of this o^-antitrypsin inhibitor in seminal fluid.
Isolation of the guinea pig seminal vesicle inhibitor by
FINK and coworkers (17, 18, 19) in our laboratory by
affinity chromatography resulted in two different
inhibitors one specific for trypsin, the other for trypsin
and plasmin. The molecular weights are in the region
of 6000. By various isolation procedures several iso-
inhibitors are obtained. They differ slightly in amino
acid composition. It is possible that the appearence of
some of the different components is the result of the
purification procedure. From boar seminal plasma a
trypsin-plasmin inhibitor was also isolated by FINK and
coworkers (19), the molecular weight found by gel
filtration experiments being about 12000.
From recent results of ZANEVELD and coworkers (20)
it may be concluded, that the inhibitor from boar
seminal plasma possibly exists as a dimer, as the mole-
cular weight of the inhibitor isolated by this research
group is about 6800, calculated on the basis of the
amino acid composition.
According to our findings the biosynthesis of the in-
hibitor from sex glands is under hormonal control,
whereas that of other organ inhibitors is not (13, 14,
21). Figure 2 shows that castration of mice results in a
decrease of inhibitor concentration, whereas the ad-
ministration pf testosterone stimulates inhibitor syn-
thesis in normal and castrated mice. Initially the in-
crease of inhibitor concentration is paralleled by the
growth of the seminal vesicles in castrated mice
during testosterone administration. But in a later state
the growth increment ceases, whereas the inhibitor
concentration continues to rise. Examination of the
inhibitor concentration in normal and pathological
sperm plasma of man also reveals a hormone dependence
(21). Inhibitor concentration is correlated with the
activity of the hormone-producing LEYDIG'S cells but
not with the function of the spermatozoa-producing
cells, which could be shown in andrological patients.
30 40
[days]
Fig. 2
Influence of testosterone on the inhibitor concentration (Inhibitor-
Milliumts/g, ImE/g) of seminal vesicles in normal and castrated mice(13)
^ = normal Δ = normal + testosteroneΟ = castrated Ο = castrated + testosterone
Estimation of sperm plasma inhibitor makes it possible
to differentiate between the inhibitor producing and the
fructose producing functional parts of the seminal vesicle,
which are both hormone dependent.
It seems, that in contrast to other inhibitors, we know
a little bit more about the possible function of this
inhibitor. The fact that the acrosomes of spermatozoa
show changes in their proteolytic activity in their
different functional states suggests the implication of an .
inhibitor (Tab. 6). Spermatozoa, produced in the testis
and stored in the epididymis come in contact with
seminal plasma during ejaculation. From the vagina
they migrate through the cervix into the uterus. Here
after a period of several hours they become fertile
(for literature see 1. c. (20)). This process of the so called
capacitation is necessary to enable the sperms to pene-
trate the outer layers of the ovum, which is accom-
plished by means of a proteolytic enzyme, located in
the acrosome, the so called acrosin (Tab. 7).
The table shows the biochemical properties of acrosin.
A similarity with trypsin and plasmin is evident. So far
acrosin has been demonstrated in sperm of rabbit
(20, 22), sheep (22), bull (22, 23), pig, horse, monkey,
human (22, 24), and chicken (22, 25). Acrosin activity in
ejaculated sperm is low in species with high inhibitor
content in seminal vesicles and vice versa. Epididymal
sperm usually shows high acrosin activity.
Tab. 6
Acrosin activity of various acrosomal extracts
Low values are caused by complex formation between acrosin and
inhibitor from seminal plasma. (ZANEVELD and coworkers (20))
Sperm Extract m Units/mg Protein
Capacitated
Epididymal
Ejaculated (crude)
Ejaculated(after DEAE column chromatography)
80—130
84—430
0—10
40—150
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Tab. 7
Properties of Acrosin and other mammalian trypsinlike enzymes
Comparison of acrosin and other mammalian trypsinlike enzymes on the basis of physico-chemical properties, enzymatic specificity, and
inhibition by several natural and synthetic inhibitors. (ZANEVELD and coworkers (20))
Properties
Molecular weight
Autoproteolysis
Stability at low pH
Optimum pH
Calcium activation
Acrosin
55.000
8
+
Pancreatic
Trypsin
23.800
8
•f
Plasmin
82.900
ί
+
fhrombin
33.000
Τ
4-
Plasma
97.000
U
— —
Kallikrein
Organs
33.000
IT
• — — —
Urine
36.300
8.5
~
Relative activity on substrates:
BAEE » Benzoyl arginine ethyl ester + +
TAME = Tosyl arginine methyl ester +
ATEE = Acetyl tyrosine ethyl ester —
Inhibitors:
TLCK = Tosyl lysine chloromethyl ketone -f-
TPCK = Tosyl phenylalanine chloromethyl ketone —
DFP = Diisopropyl fluorophosphate +
Soybean Trypsin Inhibitor +(KUNITZ) Pancreatic Trypsin Inhibitor +(Chicken) Ovomucoid Trypsin Inhibitor ±
Seminal Vesicle Trypsin Inhibitors:
TI = Trypsin inhibitor +
TPI = Trypsin plasmin inhibitor -j-
+ 4-
-f
ZANEVELD and coworkers suggest that the acrosin
inhibitor complex is formed during ejaculation by
penetration of an inhibitor from the seminal plasma
through the outer acrosomal membrane of the sperm
head. Dissociation of the complex seems to be the
mechanism Of capacitation. Acrosin sedms to be spe-
cific for penetrating the zona pellucida of the ovum,
whereas another acrosome enzyme, the so called
"corona penetrating enzyme" enables the sperm to
penetrate the corona radiata (for literature see 1. c. (18),
(20)). In decapacitated sperm complexes exist between
acrosin and the inhibitor of seminal plasma and between
corona penetrating enzyme and "decapacitation factor",
a large polypeptide, occuring also in seminal plasma.
The decapacitation factor seems to be specific for in-
hibiting the corona penetrating enzyme. It does not
inhibit trypsin or acrosin. The presence of one or both
the inhibitory activities (trypsin inhibitor from seminal
plasma and decapacitation factor) prevents the sperma-
tozoa from penetrating the corona radiata and (or) the
zona pellucida of the ovum in vitro (20, 24, 27).· With
regard to inhibition of acrosin there seems to exist no
species specific differences. In other words, the acrosin
inhibitor of one species can inhibit the acrosomal en-
zyme of another species (20, 24).
Fertilization in vivo and in vitro is significantly reduced
by adding several natural trypsin inhibitors to capa-
citated sperms, but the highest activity in this respect is
exerted by the inhibitor from seminal vesicles (20, 22,
27, 28, 29). How the dissociation of the enzyme in-
hibitor complex is accomplished in the uterus is still a
matter of speculation. ZANEVELD (20) suggests that
there occurs as well a modification of permeability in
the plasma and outer acrosomal membranes as a dis-
sociation of the acrosin inhibitor complex depending
on the half life of the reversible complex. Furthermore
the decapacitation factor can be destroyed by proteolytic
enzymes and may be accessible' to acrosin.
Necessity of capacitation for fertilization does still not
fully explain the significance of the inhibitors. There is
some evidence that protection of the spermatozoa as
well as of the mucosal membranes of the genital tract is
achieved. Capacitated sperm can penetrate uterine cells
arid tissues (30, 31, 32). It may be of interest that we
could isolate a trypsin-like enzyme from leucocytes,
which is inhibited by the inhibitor from seminal ves-.
icles (24, 33). This enzyme may be involved in the
process of phagocytosis.
The factjthat inhibitors can prevent fertilization has
stimulated experiments with the aim of finding contra-
ceptive methods. According to ZANEVELD and co-
workers (20) fertilization of rabbits is inhibited in vivo
by addition of the basic bovine trypsin inhibitor or by
partially purified rabbit sperm plasma inhibitor to
capacitated sperm prior to artificial insemination.
Although the above described trypsin inhibitor and the
trypsin plasmin inhibitor both inhibit acrosome en-
zymes, which are necessary for the spermatozoa to
penetrate the ovum, the divalent inhibitor is much
more active in preventing fertilization. No satisfactory
results were achieved by SCHUMACHER and coworkers
(34) using the basic bovine trypsin inhibitor (Trasylol2))
in experiments with mice and rabbits, in which male
and female animals were treated systemically. *
Inhibitors in the secretion of the human femal
genital tract
Our research group (35) could also demonstrate the
presence of a low molecular weight inhibitor in the
human female cervical secretion. It inhibits trypsin and
chymotrypsin but not plasmin, thrombin, and pan-
creatic kallikrein. Inhibition is instantaneous and per-
manent. This inhibitor has the lowest molecular weight
of the hitherto known polypeptide type proteinase
inhibitors. At present nothing is known about its
function nor about possible changes in concentration
during the ovulatory cycle.
SCHUMACHER (36) (for further literature see also 1. c.
(36)) could demonstrate the presence of o^-antitrypsin in
cervix mucus by radial immunodiffusion technique.
The concentration of the inhibitor depends on the
2) Trasylol, trade mark Bayer-Leverkusen,
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hormonal situation during ovulatory cycle, being at
a minimum prior to ovulation and increasing signi-
ficantly after ovulation. The same pattern of changes in
inhibitor concentration is achieved by sequential ad-
ministration of hormonal contraceptives. In this con-
nection it may be mentioned that biosynthesis of plasma
inhibitors is also hormone controlled. During preg-
nancy and under long term treatment with hormonal
contraceptives a considerable increase in o^-antitrypsin
and slight increase in a2-macroglobulin occurs (37).
The possible function of these inhibitors is still subject of
hypothesis. Inhibitor concentration in cervix secretion
is low at the time where cervical mucus displays pro-
perties which are favourable for sperm penetration.
Since cervical mucus can be depolymerized by proteo-
lytic enzymes and seminal fluid contains proteinases
including chymotrypsin-like activity besides the acro-
some-bound enzymes (38) it may be that the inhibitors
from cervical mucus function in the control of sperm
migration through the cervix.
Trypsin inhibitor f rom colostrum
LASKOWSKI and coworkers (39—42) demonstrated
trypsin inhibiting activity in human, bovine, and
porcine colostrum. The concentration is always highest
on the first day post partum and then decreasing in the
next few days. From more detailed studies of the
biochemical properties it is obvious that the inhibitors
of the various examined species were not identical.
Molecular weight of the bovine inhibitor is approxi-
mately 10500 (41), that of porcine inhibitor 6000 (42).
Porcine inhibitor is not attacked by pepsin (42), where-
as bovine inhibitor has low resistance toward pepsin
(41, 43). In contrast to pig colostrum inhibitor, which
only inhibits trypsin, bovine inhibitor shows some
activity against chymotrypsin (43, 44). In bovine
colostrum we found an inhibitory activity against
kallikrein (45).
Determination of the primary structure of cow col-
ostrum trypsin inhibitor by CECHOVA and coworkers
(46, 47, 48) shows a fairly good resemblence with the
primary structure of the bovine pancreas inhibitor. In
the isolation procedure, cow colostrum trypsin in-
hibitor resolves into 3 components, of which 2 have
identical amino acid sequence, the third being only
slightly different. Figure 3 compares the amino acid
sequences of cow colostrum trypsin inhibitor and the
basic trypsin inhibitor from bovine pancreas. The location
of at least 21 amino acid residues is identical, furthermore
the position of the 3 disulfide linkages and the amino
acid sequence around the reactive lysine necessary for
trypsin binding in cow colostrum trypsin inhibitor (44)
as well as in basic pancreatic trypsin inhibitor. Homol-
ogy in the structure of these two inhibitors exceeds
40%. This permits the conclusion that the genes for
both inhibitors are of the same phylogenetic origin. It
is most likely that during evolution one gene became
duplicated and mutations led to differentiation. From
this point of view the questions arise, whether cow
colostrum trypsin inhibitor resembles the bovine basic
inhibitor from organs, especially with regard to function
and in which way it is connected with colostrum tryp-
sin inhibitor from other mammals also with regard to
function and phylogenetic origin. A decisive difference
between basic pancreatic trypsin inhibitor and cow
colostrum trypsin inhibitor has to be held in mind:
basic pancreatic trypsin inhibitor from glands is not
secreted (as in pancreas and seminal vesicles), whereas
cow colostrum trypsin inhibitor is secreted. Basic
pancreatic trypsin inhibitor in pancreas or seminal
vesicles is furthermore accompanied by a trypsin inhibi-
tor which is found in the corresponding secretions.
A possible physiological function of colostrum trypsin
inhibitor could be protection of the maternal immune
bodies in the colostrum against degradation by trypsin
during their passage through the small intestine so
that they are absorbed intact (for literature see 1. c. (10)).
This was in part concluded from the fact, that the in-
hibitor is not attacked by pepsin and so passes the
stomach without loss of activity. But in the light of
newer results this holds only true for porcine not for
cow colostrum trypsin inhibitor. It is e. g. known that
calves as well as pigs resorb colostral proteins undigested
in the first few days of life, but various experiments, in
which several species (e. g. pigs, rats, rabbits) were fed
different proteins including y-globulins together with
en
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Phe-Gln-Thr-Pro
1
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Pro-Asp
Pro-Asp;
Arg-Tyr-Phe-Tyr-Asx
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Cy.
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Thr
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Glu-Pro-ProGln-Gln-Thr-A*p-Ly»-Scr
58
Gly-Gly-Ak
Fig. 3
Cow colostrum inhibitor (CTI) and basic
trypsin inhibitor from bovine pancreas(BPTI) show homology in primary struc-
tures, which exceeds 40%. Regions marked
I I are homologous. * marks the reactive
sites of both inhibitors.
(CeciiovA and coworkers (48))
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different proteinase inhibitors gave contradictory results.
But whether the inhibitor may influence the gastroin-
testinal function of the neonatal in different way
compared with the fully grown was not «investigated
(for literature see 1. c. (10) and (49)). Recently BAINTNER
(49) could demonstrate the presence of unchanged colo-
strum inhibitor in the urine of neonatal pigs. Proteinuria
as well as excretion of colostrum inhibitor into the urine
is demonstrable only as long as genuine proteins are
absorbed from the porcine neonatal intestine, which is
about one and a half postnatal days. During the protein
absorption period eosinophilic droplets are present in the
epithelial cells of the small intestine. These droplets give
protein reactions but are indigestible by trypsin. BAINTNER
(49) concludes from his studies that the trypsin inhibitor
is absorbed and exerts a protein protecting function.
Analogous experiments with other species must show
whether colostrum trypsin inhibitor has the same
function in other species. It is e. g. known, that immune
bodies in the human are transferred via placenta. This
may be the reason, why the inhibitor concentration in
human colostrum is very low compared with that of
other species.
Inhibitor from nasal and bronchial mucosa
and secretions
In screening tests HAENDLE (15, 50) of our research
group could demonstrate inhibitory activity against
chymotrypsin and other proteolytic enzymes in nasal
and bronchial mucous membranes and their secretions
of human and other mammals. The highest concen-
tration was found in nasal secretion, whereas the
concentration in bronchial mucous membrane was
much lower. The inhibitor concentration in the se-
creting tissues is about the same as in the respective
secretions. Trypsin, and pronase are also inhibited in
addition to chymotrypsin, whereas kallikreins are not.
A more detailed study of the inhibitor in nasal secretion
by HOCHSTRASSER and coworkers (51) from our group
suggests a molecular weight of about 13000. The
inhibitor is different from plasma inhibitors. We found
that inhibitor concentration decreases during in-
flammation in the nasopharyngeal area (52).
A recently described trypsin inhibitor in total lung
tissue of hamster and guinea pigs (53) seems to be
related to the inhibitor found by us. Lung tissue in-
jury, which was achieved by NO2 inhalation at high
pressure for up to 14 days generally results in an in-
crease of inhibitor concentration in hamster and guinea
pig lungs to more than double the control values.
Inhibitor in lacrimal fluid
Recently another glandular secretion, namely human
tears, was investigated for the presence of an inhibitor
by KUEPPERS (54). An inhibitor for trypsin and chymo-
trypsin was found (activity against other enzymes was
not yet tested). The molecular weight of this inhibitor
is assumed to be in the range of 6000. Concentration in
lacrimal fluid varies over a wide range, even in the same
individual from day to day. After stimulation of the
glands the inhibitor concentration decreases.
The latter two inhibitors may exert a protective function
against naturally occuring proteinases, mainly of
bacterial and leucocytic origin.
Inhibitor f rom dog submandibular gland
In 1963 our research group (55) found an inhibitor
with a widespread inhibition spectrum in submandibular
glands of dogs ((14), for further literature see 1. c. (10)).
We thought the occurrence of the inhibitor might be
restricted to Carnivores (Canidae et Felidae), as we could
demonstrate it in submandibular and sublingual gknds
of dogs, foxes, cats, and lynxes only. But recently a
similar inhibitor in human submandibular gland was
found by GE KAS and coworkers (56). With regard to
nutrition man belongs to the group of omnivores. The
inhibitor is not found in the parotid glands which on
the other hand in cattle are a rich source of bovine basic
(pancreatic) trypsin inhibitor. Like the specific pancreatic
trypsin inhibitor, the dog submandibular inhibitor is
secreted. Inhibitor concentration in dog submandibular
gland is the highest found in animal tissues.
With regard to the inhibition spectrum this inhibitor is
indeed "polyvalent". Besides bovine trypsin and chymo-
trypsin it inhibits subtilem (Νονό), porcine pancreatic
ekstase, Aspergillus ory^ae protease, and part of the
proteolytic activity of pronase. Porcine plasmin is also
inhibited, but to a much lesser degree than the other
proteinases. Neither inhibition of porcine pancreatic
kallikrein nor inhibition of collagenase occurs (57).
Isolation of 4 inhibitor components, which we
assume are synthetized by mutated genes, was achieved
using several methods. There are only slight differences
in amino acid composition. The calculated molecular
weight for the different components is about 13000. It
is most likely, that the inhibitor is present in a mono-
meric state. The number of disulfide bridges (based
on the molecular weight) corresponds to that of many
other inhibitors from animal organs (e. g. pancreas,
seminal vesicles, bovine organs) (57).
Our knowledge of a possible physiological function of
this inhibitor is practically zero. As it occurs mainly in
Canidae and Felidae and, as it inhibits bacterial protein-
ases, it could protect the upper gastrointestinal tract
against the action of proteinases of bacterial origin
ingested with the food.
The fact that dog submandibular inhibitor is de-
graded by pepsin might not contribute to its physiolo-
gical action as it shares this property with the porcine -
colostrum inhibitor as well as with the specific trypsin
inhibitor from pancreas and the inhibitor from semi-
nal vesicles. Pepsin does not play a role at the possible
place of function of the latter two inhibitors.
Probably protection of mucous membranes of the inner
surface of the body against undue action of proteinases
is a general function of all inhibitors secreted by glands.
This conception could be valid for the inhibitors
secreted from bronchial and nasal mucosa, lacrimal
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glands, submandibular and sublingual glands, pancreas,
glandula vesicularis, and may be also for the inhibitor
found in urine and colostrum.
Inhibitor from urine
Dealing with the inhibitory activity from urine a
problem arises: to our present information it is not
clear whether it originates from plasma or whether it
is synthetized by the kidneys. So far it has not yet been
demonstrated in kidney tissue. If it is not a product of
the kidneys, can any local function be postulated as
e. g. protection of the mucous membranes of the
ureters, bladder, and urethra? More detailed studies
are necessary to answer this question, e. g. immuno-
chemical tests should help to clarify this problem.
In 1955 ASTRUP (58, 59) found a trypsin inhibitor in the
urine of pregnant women which he named "mingin".
This inhibitor was then mainly studied by ASTRUP and
coworkers and FAARVANG and coworkers (for lite-
rature see 1. c. (10)). It is a heat stable, acidic polypeptide.
Hydrolytic cleavage of mingin by acid yields sialic acid
and a polypeptide free from sialic acid which possesses
the total inhibitory capacity. It was named minginin.
For mingin a molecular weight of 30000 or 34000 is
reported. Mingin inhibits trypsin, chymotrypsin, and
to a much lesser degree plasmin.
The inhibitor from urine was 'again described by
SHULMAN and coworkers (60). Inhibition of blood
clotting as well as of trypsin and chymotrypsin was
observed. This research group found a molecular
weight of 16700. For comparison serum inhibitors
have molecular weights of more than 50000. But there
remains the possibility that the inhibitor from urine is
a serum inhibitor degradation product, which is still
active.
Mingin is also thought to be responsible for the hyalu-
ronidase inhibiting activity of urine whereas it is not
known whether an elastase inhibiting component is
related to mingin. In cases of experimental injuries to
renal tubules in rats an inhibitor for urinary kallikrein is
excreted, which is also thought to be a component of
pksma (61).
Data on normal and pathological values of urine in-
hibitor are mainly reported by FAARVANG and cowor-
kers (for literature see 1. c. (10) and (62)). Normal
values vary in a wide range. Inhibitor excretion shows
a parallelism with the excretion of 17-oxosteroids.
Increment of inhibitor excretion is achieved by ad-
ministration of ACTH, cortison, or hydrocortison, also
some influence of glucocorticoids is reported. From
these facts FAARVANG deduces a regulation of in-
hibitor metabolism by the hypophysis-suprarenal system.
A significant increase of inhibitor excretion is observ-
ed during pregnancy. These hormone dependent
variations of inhibitor excretion in urine are paralleled
by the hormonal influence on inhibitor concentration
e. g. in plasma or cervical mucus.
Inhibitors from skin
Assumption of an analogous protective function for the
outer surface of the body, the skin, is up to now solely
speculative. An inhibitor for dermoproteinases from
skin has been described, but it could only be demon-
strated during the disappearance of Arthus phenomenon.
Besides dermoproteinases this inhibitor inhibits papain
but not trypsin or chymotrypsin (for literature see
1. c. (10)). More recent or more detailed results are not
available. The lack of greater amounts of inhibitor in
skin may, with regard to a possible protective function,
be connected with a lesser susceptibility of the outer
body surface to the action of proteinases and with a
lesser vulnerability compared with mucous mem-
branes.
Some information on the occurrence of inhibitory ac-
tivity in the skin of several fishes is available from the
work of REICHENBACH-KLINKE (63) and may throw
some light on this problem. The skin of various fresh-
and saltwater fishes contains fairly high amounts of
trypsin inhibiting activity. A corresponding inhibitory
activity can also be demonstrated in gills, liver, ovary,
and testis of these fishes in varying amounts. In skin
extracts of fishes whose skin is infected with parasites
or fungi the inhibitory activity was increased. The
increase of inhibitor concentration could also be caused
by an augmented synthesis in fish skin as well as by the
contribution of a parasitic inhibitory activity. It may be
that the relation between host — in this case the skin
of the fish — and parasites and the relation between
various parasite species on fish skin is regulated by
inhibitors. A bactericidal and fungicidal property of
fish skin is known, the mechanism of which could be
enzyme inhibition. So in the special case of fishes,
protection of the skin is most probably the physiological
role of the skin inhibitor.
Serum inhibitors
A whole spectrum of inhibitors exists in blood plasma.
Here only some topics, especially related to a proposed
physiological function, can be considered. An in-
hibitory capacity of serum against proteinases had
already been observed at the end of the last century.
But only recent developments in electrophoretic and
immune electrophoretic methods made it possible to
differentiate the various inhibitors and to examine them
in detail. This is mainly due to HEIMBURGER, SCHWICK
and coworkers (64, 65), who worked on human serum
inhibitors and the discussion will be limited to these.
According to HEIMBURGER (64, 65), six different
proteinase inhibitors can be separated from human
serum. Table 8 shows the physicochemical charac-
teristics. In contrast to the other mammalian inhibitors,
serum inhibitors have a much higher molecular weight.
a^Antitrypsin with 54000 shows the lowest, a2-
macroglobulin with 820000 the highest. These two
inhibitors, which differ so much in molecular size,
show almost identical inhibition spectra. Possibly in
this way a protective action against the respective
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Tab. 8
Concentration and physicochemical characterization of the inhibitors in human serum
(HEIMBURGER and SCHWICK (64))
Inhibitors
1. c^-Antitrypsin
2. ai-Antichymotrypsin
3. Inter «-Trypsininhibitor
4. Antithrombin I I I
5. Cl-Inactivator
6. «a-Macroglobulin
mg/100 mi
C. Mean ± SD
290.0 ± 45.0
48.7 ± 6.5
50.0
29.0 ± 2.9
23.5 ± 3.0
260.0 ± 70.0
MW
54.000
69.000
160.000
65.000
104.000
820.000
uIAol Peptide
Content (%)
54.0
7.0
3.1
4.5
2.3
3.3
86
73
90
85
65 f
92
Carbohydrate
Content (%)
12.2
24.6
8.4 .
13.4
34.7
7.7
701.2
Tab. 9
Inhibitory specificity of human serum inhibitors
(HEIMBURGER and SCHWICK (64))
I.
2.
3.
4.
δ.
6.
Inhibitors
«j-Antitrypsin
c^-Antichymotrypsin
Inter α-Try psin inhibitor
Antithrombin III
Cl-Inactivator
*2-Macroglobulin
Trypsin Chymo-
trypsin
+ +
— +
+ weak
+ —
weak weak
+ +
Enzymes
Plasmin Plasma- Pancreas- Thrombin Cl-Esterase Elatetase
Kallikrein Kallikrein
+ ? + - - +
. — — ? — . — . — —
— =. ? — — — - —
weak — — + — —
+ -f — —- + —
t + ... "Γ + -...- "" +
? not yet determined
enzymes under different conditions is assured. The
concentration of c^-antitrypsin expressed as μιηοΐ is
almost three times that of the sum of the other five
inhibitors. A high portion of carbohydrate in the in-
hibitor molecules is characteristic for the serum in-
hibitors but seems not to be necessary for the inhibitory
function.
With the exception of o^-antichymotrypsin and the
inter-a-trypsin inhibitor, the plasma inhibitors show a
broad inhibition spectrum (Tab. 9). In addition to the data
given in the Table the inhibition spectrum of o^-anti-
trypsin and a2-macroglobulin extends to collagenase
(66).
An inhibition of plasma kallikrein is known to occur
only by the action of C l-esterase inhibitor and by a2-
macroglobulin, whereas a progressive inhibition of
organ kallikreins was found to be caused by o^-anti-
trypsin (67). Inhibition of organ kallikrein by serum is
species-specific in so far as the serum inhibitor com-
bines with organ kallikreins of different mammalian
species to different degrees.
The phenomenon of species specificity extends to many
inhibitors and enzymes of various species, but attention
has been drawn to it only recently. It is of great interest
for phylogentic problems as well as for experimental
studies working with biological material of various
sources. It is of lesser importance regarding a phy-
siological function of inhibitors as the process of
inhibition normally occurs in one organism and species
differences need not be taken into account.
Trypsin is inhibited by five out of six plasma inhibitors.
The inhibition is stoichiometric and irreversible. The
affinity of trypsin to a2-macroglobulin is sevenfold
stronger than to the other inhibitors. Furthermore
1 mole of a^macroglobulin binds two moles of trypsin.
a2-Macroglobulin bound to plasmin and kallikrein can
still inhibit trypsin but to a lesser degree. The trypsin
inhibitor complex still shows a rather high residual
activity (80%) when tested with low molecular weight
synthetic substrates. This phenomenon is also observed
with other enzyme-plasma inhibitor complexes. The
inhibitor bound to the enzyme may be a steric hindrance
for the reaction, of this enzyme with a large substrate
molecule but not with a small synthetic substrate
molecule (for literature see 1. c. (64)).
a2-Macroglobulin bound trypsin still exerts some
activity on natural substrates. HEIMBURGER (64) re*
ported on the activation of plasminogen by a2=macro-
globulin-bound trypsin. This rather low enzymatic
activity nevertheless could be of importance as it is
within a physiological range and will no longer be
bound by the other trypsin inhibitors which, with
respect to their combined great inhibitory capacity,
would possibly not allow any enzymatic action of
trypsin in plasma.
For all plasma inhibitors we have to deal with the fact
that their inhibitory capacity is many times that of the
respective enzyme activity, when the total enzyme
content is fully activated. Possibly the quantitative
relation between the total amounts of enzyme and in-
hibitor is irrelevant for physiological,1 considerations,
where only the local concentrations of enzyme and in-
hibitor are important.
Thus the question arises whether an aqtive enzyme can
have a chance at all to act iri plasma. It has been men-
tioned already, that inhibitor bound enzymes are
not fully devoid of enzymatic activity. On the other
hand the rate of enzymatic activity in the presence of
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No. 80-F Fluoromefrisches Verfahren: Erfordert nur 0,01 ml Serum.
ADP + Phosphocreatin -»ATP + Creatin. Gemessen wird die Fluoreszenz von Creatin in Gegenwart von Ninhydrin.
Besteck No. 80-F 20 Bestimmungen $ 17,75 Besteck No. 80F*C 100 Bestimmungen $ 49,50
No. 40-UV — Kinetisches UV-Verfahren bei 340 nm. Erfordert 0,2 ml Serum.
ATP-f Creatin -»ADP + Phosphocreatin. Gemessen wird ADP im gekoppelten Optischen Test in Gegenwart von PyruvaN
kinase, LDH und NADH, auf Grund des Extinktionsabfalls bei 340 nm infolge Oxidation des NADH.
Besteck No. 40-A 15 Bestimmungen § 25,00 Besteck No. 40-C 90 Bestimmungen $ 138,50
Besteck No. 40-B 45 Bestimmungen $ 70,00
No. 45-UV — UV-Stat-Verfahren bei 340 mm. ?~~~
Alle Reagenzien sind in Ampullen für Einzel- oder Serienbestimmungen vorgegeben. Nach Zugabe von Wasser und 0,1 ml
Serum wird äquilibriert. Die Extinktion wird zu Beginn und nach 5 Minuten abgelesen. Ungewöhnlich einfach, bequem und
schnell.
Bestell-No. 45-1 Ampullen für Einzel-Bestimmungen 10 Ampullen für 10 Bestimmungen $11,50
Bestell-N o. 45-5 Ampullen für fünf Bestimmungen 10 Ampullen für 50 Bestimmungen $42,50
No. 910 — Automatisiertes kolorimetrisches Verfahren.
Eine automatisierte Version unseres Verfahrens No. 520. Obwohl dies wahrscheinlich das genaueste zur Zeit erhältliche, auto-
matisierte Verfahren ist, führen wir jetzt mit unserem verbesserten Verfahren No. 911, in welchem das a-Naphthol Reagenz
durch das haltbarere Orcin ersetzt wird, eine Feldstudie durch. Die Preise sind dieselben wie für No. 910. Anfragen oder
Bestellungen werden erbeten. Selbstverständlich garantieren wir für Ihre Zufriedenheit.
Besteck-No. 910-A 300 Bestimmungen $104,00 Besteck-No. 910-B 1500 Bestimmungen $381,50
Ferner ist erhältlich: CPK Bezugsenzym, ein sorgfältig getestetes Präparat, welches als Kontrolle oder Bezugsgröße für die
verschiedenen von Sigma angebotenen CPK-Verfahren benutzt werden kann. Je nach Bedarf in zwei Größen erhältlich. Aktivität:
30—50 Sigma-Einheiten pro ml nach Auffüllen mit Wasser.
CPK-1 AmpullenfüM ml 10 Ampullen $8,75 CPK-2 Ampullen für 2ml 10 Ampullen $12,50
Wir übernehmen sämtliche normalen Versandkosten für diese Reagenzien — an jeden Ort der Welt.
Sigma Technical Bulletins für die oben aufgeführten Methoden sind auf Anfrage gratis erhältlich.
Es ist ein Vergnügen, Geschäfte mit Sigma zu machen
Bestellen Sie direkt — R-Gespräch von überall her in der Welt. Tagsüber von Haus zu Haus, 314-771-5750 (einschließlich
samstags und sonntags bis 13 Uhr). Nachts von Person zu Person, Dan Broida, 314-993-6418 TWX (Fernschreiber) Tag und
Nacht: Rückantwort 910-761-0593
Sigma-Reagenzien sind in der ganzen Welt durch den Fachhandel oder direkt aus St. Louis beziehbar.
Telegramme: SIGMACHEM, St. Louis, Missouri
Die Forschungslaborotprien von
^ E M I C A L C Q M P A N Y
MAILING ADDRESS: P. O. BOX 14508, ST. LOUIS, MO., 63178, U.S.A.
^^^^•'' M A N U F A C T U R E R S OF T H E , F I N E S T B I O C H E M I C A L S A V A I L A B L E ^^^^ |^
..
Vertreten durch
SIGMA LONDON Chem. Co. Ltd. · 12, Lettice St., London, S.W. 6.. England
Telephone: 01-736-5623 (Reverse Charges)
SIGMA ISRAEL Chem. Co. Ltd. · 28 Kaf-Gimel St., Givataim, Israel
telephone: (03) 76 06 54 (Reverse Charges)
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The interrelationship between the various enzyme systems of blood
and the regulatory function of the inhibitors (HEJMBURGER and
SCHWICK 64)
upper section: > main action of enzyme
> side action of enzyme
lower section: all serum Inhibitors with exception of antithrombin III
inactivate several enzymes which is demonstrated in the figure by
different lines combining the respective inhibitor with the enzymes
excess inhibitor is determined by the mechanism of
action and the time dependence of the inhibition
reaction.
For discussion of the pathophysiological significance we
will only consider inhibition of enzymes which nor-
mally are present in blood as plasmin, thrombin,
kallikrein, and C l esterase of complement, the latter
being the only one of those enzymes which is inhibited
by only one of the serum inhibitors.
The coagulation-, fibrinolytic- and kallikrein systems
which are the main subjects of inhibition by serum
are functionally interdependent as shown by the
Figure 4 by HEIMBURGER. These systems are charac-
terized as enzymatic cascades and can be inhibited at
various stages. This, together with the fact that most
plasma inhibitors are polyvalent, provides a high
security against an undue and excessive activation of
the proenzymes.
Probably the most important function of plasma in-
hibitors is the regulation of the coagulation and of the
fibrinolytic system. Under physiological conditions an
equilibrium between these two systems is guaranteed.
Excessive coagulation as well as excessive fibrinolysis
is deleterious for the organism. Therefore the multiple
blocking mechanisms which are available to sustain the
physiological equilibrium are related to thrombin as
well as to plasrnin.
Sometimes pathology gives a clue which is apt to solve
physiological problems. Several conditions are known
in which either an increase or decrease of the serum
inhibitor level is observed.
Changes in the o^-globulin fraction result in a meas-
urable change in the trypsin inhibitor capacity of serum,
since this fraction mainly consists of aj-antitrypsin
which accounts for 90% of the trypsin inhibiting
capacity of serum. An elevated trypsin inhibitor level has
been found e. g. in metastatic carcinoma, acute diseases,
after major surgical interventions and in inflammation.
Furthermore a considerable increase in o^-antitrypsin
and a slight increase in a2-macroglobulin occurs during
pregnancy and under long term treatment with hor-
monal contraceptives and during growth. Hormonal
contraceptives also cause a drop of antithrombin III. In
this condition at least the possibility of an augmented
coagulation should be considered. Also some in-
fluence on inhibitor levels by adrenal cortical hormones
and by testosterone has been observed. This again
indicates a hormonal control of inhibitor biosynthesis
(for literature see 1. c. (10), (65), (68)).
There remains the question whether an increase of
inhibitory capacity really is of pathological significance
as normally the ratio between inhibitor and (pro)enzyme
concentration is very much in favour of the inhibitor.
As an increase of inhibitor level occurs in such different
pathological states a specific influence on pathophy-
siological mechanisms is at least questionable. It seems
that a decrease is of greater pathophysiological im-
portance.
WEBSTER, DONALDSON and others (for literature see
1. c. (10)) reported on an inherited deficiency of the
inhibitory capacity of plasma for kallikrein and C 1
esterase, which is associated with hereditary angio-
neurotic edema.
Investigations on a pathogenetic connection between an
inherited a^antitrypsin deficiency and chronic ob-
structive lung diseases were mainly carried on by
ERIKSSON and LAURELL (for literature see 1. c. (10) and
(69)). The hereditary inhibitor deficiency is carried by
an autosomal recessive gene. Homozygotes show a
reduction to 10% of the normal ai-antitrypsin value
whereas heterozygotes have about 60% of the normal
α-L-inhibitor capacity. In homozygous aj-antitrypsin
deficiency there is a high incidence of panacinar emphy-
sema, whereas it is questionable whether the hetero-
zygous state is accompanied by a higher than normal
incidence of lung disease. This again shows that even a
decrease to approximately 60% of the normal value does
not necessarily result in clinical manifestations.
ERIKSSON suggested that in o^-antitrypsin deficiency
there is an insufficient protection against the destructive
action of various proteolytic enzymes in lung tissue.
But ERIKSSON himself doubts whether this is the
correct explanation as the level of a2-macroglobulin,
which shows a similar inhibition spectrum to a^anti-
trypsin, is raised in patients with ocj-antitrypsin de-
ficiency regardless of the clinical manifestations.
Thus there are more questions than answers. Of course
it is possible that inhibitors have physiological func-
tions other than inhibition of enzymes. a2-Macroglo-
bulin, for example, is shown to have some transport
functions. Furthermore antithrombin III can combine
with fatty acids, and, the complex according to HEIM-
BURGER is no longer inhibitory (64).
In order to find out more about the physiological
functions of inhibitors it might be expedient not to
limit the study to their inhibitory activity against
proteinases.
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